references
STRATEGY
Stabilization of the Social Mission ratio
2015 SOCIAL MISSION BREAKDOWN: 87.7% OF EXPENDITURE
100% 80% 60% 40% 20% 0%
13.5 11.6
12.4 11.6
12.3 11.7
11 4
In 2015, DNDi’s non-social mission ratio remains highly stable compared to 2014. The growth in non-social mission (+EUR 0.8 M) and social mission expenditures (+EUR 5.8 M) were balanced, at 18% each. However, these steady figures mask some specific points worth highlighting: • The External Affairs department covering Communications, Advocacy, Policy affairs, and Fundraising activities experienced one of the highest growths in 2015 of all departments, with a 33% increase (+EUR 1.1 M). • Activities related to Strengthening Capacities, with 7% growth (+EUR 0.2 M), and General Administration, with 10% growth (+EUR 0.3 M) maintained the same level of activity compared to 2014, with the rise in expenditure mostly due to the increase in the CHF & USD exchange rates against the EUR.
74.9
76
76
85
2013
R&D
2014
Other social mission
2015
Business plan Forecast 2003 - 2018
Non social mission
Partnerships increase of 23% to support the growth of R&D activities
MAIN R&D PARTNERS & SERVICE PROVIDERS PER CONTINENT, with financial compensation over EUR 5,000
80 70 60 50 40 30 20 10 0
Private versus public sector ratio remains stable at around 50%/50% over the last 4 years
MAIN R&D PARTNERS AND SERVICES PROVIDERS with financial compensation over EUR 5,000
43% 40% 53%
50 57 73
57% 60%
2014
Public sector Private sector
47%
2015
24 32 40
4 3 5 201 201 201
Africa
24 20 26
5 4 3 201 201 201
Americas
16 21 21
2013
4 5 3 201 201 201
Asia and Oceania
5 4 3 201 201 201
Europe
In 2015, the number of partners and service providers DNDi had business relations valuing over EUR 5,000 with increased by 23% (160 in 2015, compared to 130 in 2014). All regions increased except Asia. The Americas saw a rise of 30% with 6 additional partners & service providers to support the new activities related to CL and Chagas access projects in Latin America. In Europe the figure progressed by 28% with 16 additional partners & service providers, reflecting the growth of the new diseases activities in 2015 in Europe. In Africa there was growth of 25%, with 8 additional partners & service providers, particularly with the Kenya office increasingly engaging local vendors for regional activities related to paediatric HIV, mycetoma, and leishmaniasis. MAIN R&D PARTNERS: FASTER GROWTH IN LOW & MIDDLE-INCOME (+27%) THAN IN HIGH-INCOME COUNTRIES (+20%)
100 80 60 40 20 0
2014 2015 2014 2015
Comparison of percentage of partnerships with the public institutional sector (research institutes, public hospitals, academic groups, universities, PDPs, and other not-for-profit organizations) with numbers of partnerships with the private sector (pharmaceutical and biotechnology companies and contract research organizations).
Steady growth in number of partnerships
NUMBER OF CONTRACTS SIGNED ANNUALLY*
120 90
137 96 84 73 106 111 122
60 30
90 75 55 70
0
2009
2010
2011
2012
2013
2014
2015
The number of contracts finalized each year follows a trend similar to that of R&D partners & service providers with a financial compensation of over EUR 5,000. There is a regular annual increase of between 5% and 15%, with 5% in 2013 and 12% in 2015.
*Except confidentiality agreements; some new contracts may be extensions.
High income countries
low and medium income countries
DNDi Annual Report 2015 › 13
2015 KEY FINANCIAL PERFORMANCE INDICATORS